Dr. Fay Kastrinos, director of the Muzzi Mirza Pancreatic Cancer Prevention and Genetics Program at Columbia University Medical Center, explains the value of genetic testing for cancer prevention and treatment.
There are a number of different genetic mutations that can cause familial pancreatic cancer. This article explains some of the most common ones.
Professor Gloria Peterson of the Mayo Clinic is working on tumor genetics to help make early detection of pancreatic cancer a reality.
Dr. Diane Simeone and her colleagues are developing a tablet-based electronic family history survey to help identify patients that may be at risk for developing pancreatic cancer because of certain genetic syndromes.
If you’ve lost relatives to pancreatic cancer or have a genetic mutation tied to the disease, joining a tumor registry can help doctors identify early detection and screening options.
In a large study, Dr. Bert Vogelstein of Johns Hopkins found that a majority of cancers, including pancreatic cancer, are caused by random mutations of DNA.
Lewis Cantley’s team is starting clinical trials of vitamin C to gain more information about its role in stopping cancer.
Trovagene is developing a liquid biopsy for pancreatic cancer patients, to allow doctors to test for cancer and track treatment response.
Dr. Robert Vonderheide of the Abramson Cancer Center at the University of Pennsylvania describes immunotherapy trials for pancreatic cancer.
The relationship between BRCA and pancreatic cancer, and how that affects treatment, is the focus of clinical trials looking at PARP inhibitors.